Latest Exploration News

Sierra Nevada Gold (ASX – SNX) has won the bid for the expansive As Safra Copper-Gold Project in Saudi Arabia, marking a major step in its global exploration strategy. Concurrently, drilling progresses at its Nevada Warrior Gold Project with results anticipated soon.

Hexima Limited reports a stable cash position of $1.4 million for the December quarter while exploring strategic options including a potential capital return to shareholders.

Jade Gas Holdings reported continuous gas production from two wells at its Red Lake coal bed methane project in Mongolia during Q4 2025, confirming commercial viability with exceptionally high methane purity. The company also secured a $70 million non-binding LOI and appointed a new CEO to drive development.

Canterbury Resources has completed a positive Scoping Study for its Briggs Copper Project, confirming a large-scale mineral resource and committing to a Pre-feasibility Study. The company also raised $1.24 million via a Share Purchase Plan during the quarter.

Australian Strategic Materials reports a significant 75% jump in NdFeB alloy deliveries at its Korean Metals Plant and advances heavy rare earth production, while announcing a transformative acquisition offer from Energy Fuels Inc.

Carnaby Resources has reported a 10% increase in its Greater Duchess Copper Gold Project resource, completed full ownership of the JV, and is advancing its pre-feasibility study with strong cash backing and promising drill results.

Nexus Minerals Limited reports significant progress at its Wallbrook Gold Project with high-grade drill results across multiple prospects and advancing permitting for Crusader-Templar. The company is positioning Wallbrook as an emerging gold camp with promising growth potential.

Taiton Resources has completed drilling at its Challenger West project and is preparing to drill at the Highway project's Yogi prospect, backed by a $2 million capital raise and a key board appointment.

Orion Minerals reported a December 2025 quarter marked by significant cash outflows offset by fresh financing, including a major convertible loan and ongoing talks with Glencore for substantial project funding.

Orion Minerals is finalising a major financing and offtake agreement with Glencore, advancing its transition to a mining company with first copper and zinc concentrate expected by late 2026.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

Felix Gold has transitioned from exploration to development with a metallurgical breakthrough producing military-grade antimony and is advancing pilot plant operations and government funding applications to meet US military demand.